Hansa Biopharma AB

(HNSBF)

By |

Profile

Hansa Biopharma AB is a biopharmaceutical company which develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in highly sensitized patients and further developed for use in other organ and tissue transplantation as well as acute autoimmune indications.

Contact Information

Website: www.hansamedical.com
Main Phone: +46 46165670
Address: Scheelevagen 22
City / Town: Lund
Country: SE
Postal Code: SE-223 63

Issuer Information

Exchange: GREY
Employees: 80
NAICS: Pharmaceutical Preparation Manufacturing (325412)

Equities News

Profile

Hansa Biopharma AB is a biopharmaceutical company which develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in highly sensitized patients and further developed for use in other organ and tissue transplantation as well as acute autoimmune indications.

Contact Information

Website: www.hansamedical.com
Main Phone: +46 46165670
Address: Scheelevagen 22
City / Town: Lund
Country: SE
Postal Code: SE-223 63

Issuer Information

Exchange: GREY
Employees: 80
NAICS: Pharmaceutical Preparation Manufacturing (325412)

Equities News

$ 29.50 $ 0. (0.00%)
Last Price 29.50 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 29.50
Last Trade Volume 0 52 Wk Hi 29.50 52 Wk Low 7.20
Market Cap 1.4 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 45,894,909.00 EPS (TTM) N/A PE Ratio N/A Exchange Greys